Botswana vs Viet Nam: HIV/AIDS deaths averted by antiretroviral therapy
Botswana
9,751 deaths
in 2024
Viet Nam
8,037 deaths
in 2024
Botswana rank
25th
Viet Nam rank
28th
HIV/AIDS deaths averted by antiretroviral therapy over time
- Botswana
- Viet Nam
How they compare
Botswana currently reports 9,751 deaths against 8,037 deaths in Viet Nam, a difference of 1,714 deaths.
That makes Botswana's figure about 1.2 times Viet Nam's.
The two have swapped places 1 time across 35 shared years of data; in 1990 it was Viet Nam ahead.
Botswana ranks 25th and Viet Nam ranks 28th of 157 countries.
Botswana has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Botswana | Viet Nam | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 14.78 deaths | 0 deaths | 14.78 deaths | Botswana |
| 2000s | 7,590 deaths | 1,430 deaths | 6,161 deaths | Botswana |
| 2010s | 14,708 deaths | 8,644 deaths | 6,065 deaths | Botswana |
| 2020s | 10,907 deaths | 8,576 deaths | 2,331 deaths | Botswana |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Botswana or Viet Nam?
- Botswana, at 9,751 deaths against 8,037 deaths in Viet Nam as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Botswana and Viet Nam?
- 1,714 deaths, with Botswana ahead.
- How many years of comparable data are there for Botswana and Viet Nam?
- 35 years are reported by both, from 1990 to 2024.
- How do Botswana and Viet Nam rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Botswana ranks 25th and Viet Nam ranks 28th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.